PCL, Inc.

KOSDAQ 241820.KQ

PCL, Inc. EBIT Margin for the year ending December 31, 2023: -197.46%

PCL, Inc. EBIT Margin is -197.46% for the year ending December 31, 2023, a -35,260.66% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

PCL, Inc. EBIT Margin for the year ending December 31, 2022 was 0.56%, a 100.90% change year over year.
PCL, Inc. EBIT Margin for the year ending December 31, 2021 was -62.17%, a -267.76% change year over year.
PCL, Inc. EBIT Margin for the year ending December 31, 2020 was 37.06%, a 100.17% change year over year.
PCL, Inc. EBIT Margin for the year ending December 31, 2019 was -21,967.34%, a -389.27% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

KOSDAQ: 241820.KQ

PCL, Inc.

CEO	Ms. Soyeon Kim
IPO Date	Feb. 23, 2017
Location	South Korea
Headquarters	Star valley, 99
Employees	31
Sector	Healthcare
Industries Biotechnology 3D Printing Cleaning Supplies Medical Instruments Non-Alcoholic Beverages Personal Care Pharmaceuticals Plastics

Description

PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers multiplex antibody and antigen diagnostic kits for the detection of antibodies to human immunodeficiency virus (HIV) 1 and 2, HBV, hepatitis C virus (HCV), and human T-lymphotropic virus 1 and 2, as well as antigens to HIV p24, HCV core, and HBV surface in human serum or plasma. It also provides Ai, an influenza A/B typing rapid diagnostic test kit; Cancer6, a multiple tumor markers screening kit; and sciLINER LATERAL FLOW DISPENSER, a dispenser for membrane materials with active visual drop volume control. In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified. PCL, Inc. is headquartered in Seoul, South Korea.

Key trends

Past 5 years